Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

SafeHeal Anastomosis Feasibility Evaluation (SAFE)-2023 Study

NCT: NCT06540807 · COMPLETED

NCT IDNCT06540807
StatusCOMPLETED
Start Date2024-07-31
Completion2025-12-26

Brief Summary

A feasibility study to assess the early safety and effectiveness of the Colovac 2 device in providing temporary protection of the anastomosis in patients undergoing low anterior resection for colon cancer.

Frequently Asked Questions

What is SafeHeal Anastomosis Feasibility Evaluation (SAFE)-2023 Study?

SafeHeal Anastomosis Feasibility Evaluation (SAFE)-2023 Study is a clinical trial registered under NCT06540807. Current status: COMPLETED.

What is the status of NCT06540807?

The current status of NCT06540807 (SafeHeal Anastomosis Feasibility Evaluation (SAFE)-2023 Study) is: COMPLETED.

When did SafeHeal Anastomosis Feasibility Evaluation (SAFE)-2023 Study start?

SafeHeal Anastomosis Feasibility Evaluation (SAFE)-2023 Study started on 2024-07-31.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑